X-Message-Number: 3000 Date: 20 Aug 94 01:53:00 EDT From: Michael Riskin <> Subject: CRYONICS:Insurance There has been discussion on the net recently concerning the desireability of cryonics organizations offering life insurance to it's members. Mike Darwin made strong supportive arguments in favor of cryonics organizations taking on this risk/ reward endeavor including his estimation of the relatively low risk involved and high fiscal desireability. In contrast, Derek Ryan indicated some trepidation in taking on an endeavor of the magnitude of member life insurance focusing on the risk factors. For a complete reading of their informative postings see cryonet messages # 2990 and 2993. There are a few additional factors I wish to mention. The profitability of life insurance as a business and the ease of risk assessment, is not as quite as clear, in my opinion, as Mike Darwin suggests. Most insurance companies maintain a complete underwriting department to evaluate new policies. This consists of highly paid personnel such as actuaries, and sophisticated computerized EVA analysis (economic value added) to attempt to *predetermine* the profitability of each policy *before it is sold*, in addition to such necessary professionals as medical and nursing personnel that Mike Darwin refers to. (EVA is a *projective* cost accounting on a policy by policy basis system, as compared to traditional *historical* cost accounting). Besides the in house capability, they also keep under contract independent risk analysis consultants at high volume-low cost advantage. Additionally, some leading edge insurers have contracts with centralized specialty testing labs that perform additional tests on blood, hair and other samples as initial data gathering dictates. And then, all this independently collected data, needs to be viewed as consistent or inconsistent with the medical records gathered also at expense from the customers personal physicians. Simply having access to the prospective insureds medical records is also not a guarantee against relying on misleading information. Membership in the national data banks is also desireable to screen and analyze applicants, also at expense. And, it is recognized that an effective risk analysis program is not meant to exclude business, but to actively find profitable business. The money currently required for suspension funding by cryonics organizations is sufficiently high to warrant this extensive analysis by insurers. This entire risk analysis process has a high upfront cost factor, spread out over many policies eventually sold, along with those rejected. They depend to a degree on the prescreening ability of qualified insurance agents to eliminate the cost of evaluating non insurable customers. Even the initial evaluation process by a paramedic or nurse is more sophisticated than it appears on the surface. When a representative is sent out to draw blood, take BP, height/weight and the history etc, from a prospective customer, there is also a trained, purposefully "casual" personal observation and interaction taking place. The field rep listens for signs of possible necessary followup in addition to the standard tests. Customer credibility is a critical issue. For example, smoking is asked about. The rep may offhandedly watch for the response after mentioning that nicotine shows up in hair samples for a very long time after asking the "do you smoke?" question. Similiar observations are made re the drug use questions, and "casual" conversation. The notes about these and other aspects of the field screen are reviewed for possible additional testing all at small or great expense to the insurance company. Such costly tests as a treadmill are sometimes required, or a PSA, and the decision to bear the expense for those are also based on less than hard evidence. This is a highly sophisticated psychological and medical evaluation. And, with all of that, the insurer then has to determine a competitive premium (they do not want to lose the customer after all that cost), at either preferred, standard, or rated premiums. And, insurers will also, after all that careful analysis, possibly choose to use reinsurers as a means of spreading risk. Finally, death claims need to be examined, and investment strategies utilized that cover the death benefits and cash values if appropriate, in addition to creating the profits. And, the insurers continue to try to improve the risk analyis/ profit process. An infrastructure of administrative and customer service resource must also be maintained at some expense. The point of all of the above, is first, that I do not currently see any cryonics organization having sufficient economy of scale to undertake the necessary up front risk analysis expenses or cover the overhead of administering to its' insureds. I believe it is far more involved, costly, and requiring far more trained personnel and sophisticated accounting to do the job properly than the spare time of a cryonics medical director, RN's, and outside contractors as Mike Darwin suggests. But, even more importantly, I believe the absolute first responsibility of any cryonics organization is to care for the resources and welfare of it's patients. If a cryonics insurance company is connected in anyway to the long term storage company, where this real and potential risk, expense and loss can affect the patients, it is unacceptable to me. If the insurance company is completely independent as a corporate entity, it then becomes less clear as to how the *possible* profits positively enhance cryonics endeavors. Besides all else, it is a well taken business observation that an entity should stick to what it knows how to do. There are very good business reasons why the largest of publicly held enterpises choose not to self insure, but rather look for the best available deal from vendors. Now, with all of that , do I unequivocably reject the idea? No I do not. As we grow, and develop appropriate resources of a financial, administrative, and technical nature, there may emerge great potential for us. We are a small band of visionaries, and I believe we are better served by pursuing suspension, storage, and reanimation progress with our current resources than profits from life insurance for now. Michael Riskin, C.P.A., Ph.D., Director and Treasurer of Alcor, speaking solely for himself and not representing an official view of The Alcor Life Extension Foundation. Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=3000